Objective To study the stability of injection of propafenone hydrochloride.
目的考察盐酸普罗帕酮注射液的稳定性。
Other drugs such as flecainide and propafenone can help maintain a normal rhythm.
其他药物，如氟卡尼和普罗帕酮可以帮助维护正常的节奏。
No significant differences of QT and QTd were found in Propafenone group(P>0.05);
结果两组患者疗效间差异无显著性意义（P＞0．05）。
Propafenone has no effects on QT interval, however it prolongs ventricular depolarization.
普罗帕酮对心室复极时间无影响，可延长心室除极时间。
Conclusion Betaloc in combination with diltiazem is superior to propafenone in treating paf.
结论倍他乐克与盐酸地尔硫联合治疗阵发性房颤疗效优于普罗帕酮。
AIM: To investigate the stereoselective metabolism of propafenone (PPF) by human liver CYP3A4.
目的：研究普罗帕酮(PPF)经人肝cyp3a 4代谢的立体选择性。
Objective: To study the electrophysiology effect of Propafenone on ventricle muscle cell of rats.
目的：研究普罗帕酮对心室肌细胞的影响作用。
Objective: To observe the combined propafenone for treatment of female menopause metoprolol arrhythmia.
目的：观察倍他乐克联合普罗帕酮治疗女性更年期心律失常的疗效。
Results After treatment, propafenone group, the better Isoptin group, and the low rate of adverse reactions.
结果经过治疗后，心律平组的疗效优于异搏定组，且不良反应率低。
Objective: To compare the efficacy and safety of intravenous amiodarone and propafenone for broad QRS tachycardia.
目的：观察和比较静脉注射胺碘酮、普罗帕酮治疗宽qrs波群心动过速的即时疗效和安全性。
Conclusion: metoprolol arrhythmia combined propafenone for treatment of female menopausal patients with curative effect.
结论：倍他乐克联合普罗帕酮治疗女性更年期心律失常患者的疗效确切。
Aim To investigate the effects of propafenone on myocardium inotropism and explore it's possible mechanism in isolated papillary muscle of guinea pig.
目的研究普罗帕酮心肌变力性作用并从组织水平探讨其作用机制。
Methods Take retrospective analysis method to 100 cases patients of PSVT, the patients were randomly divided into Isoptin group and propafenone in the treatment group.
方法对我院收治的100例PSVT患者采取回顾性分析的方法，将患者随机分为异搏定治疗组及心律平治疗组。
The pharmacokinetic parameter of patients' propafenone was measured by intravenous injection and the dosage regimen individualization by oral administration was studied.
本文经静脉注射测定了病人心律平药动学参数，并对口服心律平的给药方案个体化进行了研究。
We studied sustained release characteristics of sodium alginate (NaAlg), chitosan (cs) and their mixture, incorporation with propafenone hydrochloride (PF) as a model drug.
以盐酸普罗帕酮为模型药物，比较了海藻酸钠、脱乙酰壳多糖以及两者混合物骨架的缓释作用及释药特性。
Results: There was no obvious difference in controlling premature ventricular beats, but amiodaron was much better than propafenone in improving cardiac function and decreasing cas…
结果：两者对室早的控制无明显差异，而可达龙在心改善功能及降低病死率方面明显优于心律平。
METHODS A retrospective study was carried out, with collection, statistic and analyses 366 cases of adverse drug reactions induced by propafenone reported in domestic journals during 1994—2007.
方法：采用回顾性研究方法，对1994—2007年国内医药期刊报道的366例普罗帕酮致不良反应病例进行统计、分析。
The treatment group 36 cases, using propafenone tablets metoprolol combined treatment, the control group 28 cases, a separate sheet with propafenone treatment, both groups were treated for 4 weeks.
治疗组36例，采用倍他乐克联合普罗帕酮片治疗，对照组28例，单独采用普罗帕酮片治疗，两组均治疗4周。
The treatment group 36 cases, using propafenone tablets metoprolol combined treatment, the control group 28 cases, a separate sheet with propafenone treatment, both groups were treated for 4 weeks.
治疗组36例，采用倍他乐克联合普罗帕酮片治疗，对照组28例，单独采用普罗帕酮片治疗，两组均治疗4周。
应用推荐